サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：てんかんモニタリングデバイスの世界市場：業界動向と予測（～2030年）
市場調査レポート
商品コード
1189544

てんかんモニタリングデバイスの世界市場：業界動向と予測（～2030年）

Global Epilepsy Monitoring Devices Market - Industry Trends and Forecast to 2030
出版日: | 発行: Data Bridge Market Research | ページ情報: 英文 532 Pages | 納期: お問合せ

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
てんかんモニタリングデバイスの世界市場：業界動向と予測（～2030年）
出版日: 2022年12月01日
発行: Data Bridge Market Research
ページ情報: 英文 532 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のてんかんモニタリングデバイスの市場規模は、2023年～2030年の予測期間に5.6%相当のCAGRを記録すると予測されています。

てんかんの有病率の上昇、ウェアラブルてんかんモニタリングデバイスへの嗜好の高まり、てんかんプロジェクトへの政府投資の増加、てんかんの研究開発活動の活発化などが、世界のてんかんモニタリングデバイス市場の主要な成長促進要因です。

当レポートでは、世界のてんかんモニタリングデバイス市場について調査分析し、市場概要、セグメント別・地域別の市場分析、競合分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 世界のてんかんモニタリングデバイス市場：内訳

第3章 エグゼクティブサマリー

第4章 重要考察

  • 重要考察
    • 主要な戦略的イニシアチブ
    • 発作の発生：時間別

第5章 疫学

  • てんかんの発症率と有病率：国別
    • 全般発作：患者タイプ別
    • 焦点発作：患者タイプ別

第6章 世界のてんかんモニタリングデバイス市場：規制の枠組み

  • 医療機器
  • ウェアラブル医療機器

第7章 市場概要

  • 促進要因
    • てんかんの有病率の上昇
    • ウェアラブルてんかんモニタリングデバイスへの嗜好の高まり
    • てんかんプロジェクトへの政府投資の増加
    • てんかんの研究開発活動の活発化
  • 抑制要因
    • 複雑なてんかんモニタリング手順・デバイス関連の高コスト
    • てんかんモニタリングデバイスの製品リコールのシナリオ
  • 機会
    • 疾患モニタリンんぐデバイスの技術進歩の上昇
    • 非侵襲性・低侵襲性のデバイスに対する需要拡大
  • 課題
    • 不十分な償還シナリオ
    • 製品承認のための厳格な規則と規制

第8章 世界のてんかんモニタリングデバイス市場：製品タイプ別

  • 概要
  • ウェアラブルデバイス
    • スマートウォッチ
    • その他の非侵襲性モニタリングデバイス
  • スマートデバイス
    • モーションモニター
    • ビデオモニター
    • マットレスデバイス
    • その他
  • 従来型デバイス
    • 脳波デバイス
    • 筋電計（EMG）デバイス
    • 心電図（ECG）デバイス
    • パルスオキシメータ
    • 埋め込みアドバイザリーシステム
    • 三軸加速度計（ACM）
    • 磁力計
    • その他のデバイス

第9章 世界のてんかんモニタリングデバイス市場：タイプ別

  • 概要
  • 焦点発作
    • 単純焦点発作
    • 複雑性焦点発作
    • 二次性全般発作
  • 全般発作
    • 強直間代発作
    • 欠神発作

第10章 世界のてんかんモニタリングデバイス市場：患者タイプ別

  • 概要
  • 小児科
  • 高齢者
  • 成人

第11章 世界のてんかんモニタリングデバイス市場：エンドユーザー別

  • 概要
  • 病院
  • 在宅医療環境
  • 神経センター
  • 診断センター
  • 外来手術センター・クリニック
  • その他

第12章 世界のてんかんモニタリングデバイス市場：流通チャネル別

  • 概要
  • 小売販売
  • オンライン販売
  • 直接入札
  • その他

第13章 世界のてんかんモニタリングデバイス市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • シンガポール
    • タイ
    • マレーシア
    • インドネシア
    • オーストラリア
    • フィリピン
    • ベトナム
    • ニュージーランド
    • 台湾
    • その他アジア太平洋
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • オランダ
    • スイス
    • ベルギー
    • トルコ
    • デンマーク
    • スウェーデン
    • ノルウェー
    • ポーランド
    • フィンランド
    • その他欧州
  • 中東・アフリカ
    • 南アフリカ
    • アラブ首長国連邦
    • エジプト
    • サウジアラビア
    • クウェート
    • イスラエル
    • バーレーン
    • オマーン
    • カタール
    • その他中東・アフリカ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米

第14章 世界のてんかんモニタリングデバイス市場：企業情勢

  • 企業シェア分析：世界
  • 企業シェア分析：北米
  • 企業シェア分析：欧州
  • 企業シェア分析：アジア太平洋

第15章 SWOT

第16章 企業プロファイル

  • NIHON KOHDEN CORPORATION.
  • MASIMO
  • APPLE INC.
  • NATUS MEDICAL INCORPORATED.
  • OWLET.
  • ACTIGRAPH, LLC.
  • ADVANCED BRAIN MONITORING, INC.
  • CAPTUREPROFF INC.
  • EMPATICA INC.
  • EPIHUNTER
  • EPILERT
  • EPILEPSY ALARMS UK
  • EPI USA.
  • EPIVIEW
  • FREQUENCY PRECISION.
  • HIPASS DESIGN LLC
  • IBABY LABS, INC.
  • ITS DESIGNS LTD
  • LIVASSURED
  • LIVELIFE ALARMS.
  • MEDPAGE LTD
  • MIKU INC.
  • NEUROSOFT
  • NEUROTECH, LLC
  • SAFE-LIFE
  • SMARTMONITOR
  • SNUZA
  • THE 'LIFE MINDER'
  • VAHLKAMP INTERNATIONAL B.V.

第17章 アンケート

第18章 関連レポート

図表
  • 16.16 HIPASS DESIGN LLC 514
    • 16.16.1 COMPANY SNAPSHOT 514
    • 16.16.2 PRODUCT PORTFOLIO 514
    • 16.16.3 RECENT DEVELOPMENT 514
  • 16.17 IBABY LABS, INC. 515
    • 16.17.1 COMPANY SNAPSHOT 515
    • 16.17.2 PRODUCT PORTFOLIO 515
    • 16.17.3 RECENT DEVELOPMENT 515
  • 16.18 ITS DESIGNS LTD 516
    • 16.18.1 COMPANY SNAPSHOT 516
    • 16.18.2 PRODUCT PORTFOLIO 516
    • 16.18.3 RECENT DEVELOPMENT 516
  • 16.19 LIVASSURED 517
    • 16.19.1 COMPANY SNAPSHOT 517
    • 16.19.2 PRODUCT PORTFOLIO 517
    • 16.19.3 RECENT DEVELOPMENT 517
  • 16.20 LIVELIFE ALARMS. 517
    • 16.20.1 COMPANY SNAPSHOT 517
    • 16.20.2 PRODUCT PORTFOLIO 518
    • 16.20.3 RECENT DEVELOPMENT 518
  • 16.21 MEDPAGE LTD 519
    • 16.21.1 COMPANY SNAPSHOT 519
    • 16.21.2 PRODUCT PORTFOLIO 519
    • 16.21.3 RECENT DEVELOPMENT 520
  • 16.22 MIKU INC. 520
    • 16.22.1 COMPANY SNAPSHOT 520
    • 16.22.2 PRODUCT PORTFOLIO 520
    • 16.22.3 RECENT DEVELOPMENT 520
  • 16.23 NEUROSOFT 521
    • 16.23.1 COMPANY SNAPSHOT 521
    • 16.23.2 PRODUCT PORTFOLIO 521
    • 16.23.3 RECENT DEVELOPMENTS 522
  • 16.24 NEUROTECH, LLC 523
    • 16.24.1 COMPANY SNAPSHOT 523
    • 16.24.2 PRODUCT PORTFOLIO 523
    • 16.24.3 RECENT DEVELOPMENT 523
  • 16.25 SAFE-LIFE 524
    • 16.25.1 COMPANY SNAPSHOT 524
    • 16.25.2 PRODUCT PORTFOLIO 524
    • 16.25.3 RECENT DEVELOPMENT 524
  • 16.26 SMARTMONITOR 525
    • 16.26.1 COMPANY SNAPSHOT 525
    • 16.26.2 PRODUCT PORTFOLIO 525
    • 16.26.3 RECENT DEVELOPMENT 525
  • 16.27 SNUZA 526
    • 16.27.1 COMPANY SNAPSHOT 526
    • 16.27.2 PRODUCT PORTFOLIO 526
    • 16.27.3 RECENT DEVELOPMENT 526
  • 16.28 THE 'LIFE MINDER' 527
    • 16.28.1 COMPANY SNAPSHOT 527
    • 16.28.2 PRODUCT PORTFOLIO 527
    • 16.28.3 RECENT DEVELOPMENT 527
  • 16.29 VAHLKAMP INTERNATIONAL B.V. 528
    • 16.29.1 COMPANY SNAPSHOT 528
    • 16.29.2 PRODUCT PORTFOLIO 528
    • 16.29.3 RECENT DEVELOPMENT 528

17 QUESTIONNAIRE 529

18 RELATED REPORTS 532

LIST OF TABLES

  • TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 106
  • TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 107
  • TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 109
  • TABLE 4 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 5 GLOBAL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 6 GLOBAL WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 7 GLOBAL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 124
  • TABLE 8 GLOBAL SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 9 GLOBAL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 125
  • TABLE 10 GLOBAL CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 11 GLOBAL EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 12 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 13 GLOBAL FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 14 GLOBAL FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 15 GLOBAL SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 16 GLOBAL COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 17 GLOBAL SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 18 GLOBAL GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 136
  • TABLE 19 GLOBAL GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 20 GLOBAL TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)) 136
  • TABLE 21 GLOBAL ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 22 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 23 GLOBAL PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 143
  • TABLE 24 GLOBAL GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 144
  • TABLE 25 GLOBAL ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 144
  • TABLE 26 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 148
  • TABLE 27 GLOBAL HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 149
  • TABLE 28 GLOBAL HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 150
  • TABLE 29 GLOBAL NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 150
  • TABLE 30 GLOBAL DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 151
  • TABLE 31 GLOBAL AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 152
  • TABLE 32 GLOBAL OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 152
  • TABLE 33 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 156
  • TABLE 34 GLOBAL RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 157
  • TABLE 35 GLOBAL ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 158
  • TABLE 36 GLOBAL DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 158
  • TABLE 37 GLOBAL OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 159
  • TABLE 38 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 165
  • TABLE 39 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 170
  • TABLE 40 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 41 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 42 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 170
  • TABLE 43 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 171
  • TABLE 44 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 45 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 171
  • TABLE 46 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 171
  • TABLE 47 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 48 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 172
  • TABLE 49 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 173
  • TABLE 50 NORTH AMERICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 51 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 173
  • TABLE 52 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 173
  • TABLE 53 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 54 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 55 NORTH AMERICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 56 NORTH AMERICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 57 NORTH AMERICA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 58 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 59 NORTH AMERICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 60 NORTH AMERICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 61 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 62 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 176
  • TABLE 63 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 176
  • TABLE 64 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 65 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 66 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 177
  • TABLE 67 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 177
  • TABLE 68 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 69 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 178
  • TABLE 70 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 178
  • TABLE 71 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 179
  • TABLE 72 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 179
  • TABLE 73 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 180
  • TABLE 74 U.S. EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 75 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 180
  • TABLE 76 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 180
  • TABLE 77 U.S. EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 78 U.S. FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 79 U.S. SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 80 U.S. COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 81 U.S. SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 82 U.S. GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 83 U.S. TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 84 U.S. ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 85 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 86 U.S. EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 183
  • TABLE 87 U.S. EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 183
  • TABLE 88 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 89 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 184
  • TABLE 90 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 184
  • TABLE 91 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 184
  • TABLE 92 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 93 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 185
  • TABLE 94 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 185
  • TABLE 95 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 185
  • TABLE 96 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 186
  • TABLE 97 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 186
  • TABLE 98 CANADA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 186
  • TABLE 99 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 187
  • TABLE 100 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 187
  • TABLE 101 CANADA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 102 CANADA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 103 CANADA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 104 CANADA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 105 CANADA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 106 CANADA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 107 CANADA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 108 CANADA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 109 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 110 CANADA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 189
  • TABLE 111 CANADA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 189
  • TABLE 112 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 113 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
  • TABLE 114 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 190
  • TABLE 115 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 190
  • TABLE 116 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 117 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 191
  • TABLE 118 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 191
  • TABLE 119 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 120 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 192
  • TABLE 121 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 192
  • TABLE 122 MEXICO EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 123 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 193
  • TABLE 124 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 193
  • TABLE 125 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 126 MEXICO FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 127 MEXICO SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 128 MEXICO COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 129 MEXICO SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 130 MEXICO GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 131 MEXICO TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 194
  • TABLE 132 MEXICO ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 133 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 195

LIST OF FIGURES

  • FIGURE 1 GLOBAL EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 78
  • FIGURE 2 GLOBAL EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION 81
  • FIGURE 3 GLOBAL EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS 82
  • FIGURE 4 GLOBAL EPILEPSY MONITORING DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 83
  • FIGURE 5 GLOBAL EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 83
  • FIGURE 6 GLOBAL EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 84
  • FIGURE 7 GLOBAL EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID 87
  • FIGURE 8 GLOBAL EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS 89
  • FIGURE 9 GLOBAL EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID 90
  • FIGURE 10 GLOBAL EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 93
  • FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL EPILEPSY MONITORING DEVICES MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 94
  • FIGURE 12 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE GLOBAL EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030 95
  • FIGURE 13 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE GLOBAL EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030 95
  • FIGURE 14 NORTH AMERICA IS EXPECTED TO GROW WITH THE HIGHEST CAGR FOR EPILEPSY MONITORING DEVICES MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 96
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL EPILEPSY MONITORING DEVICES MARKET 112
  • FIGURE 16 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022 119
  • FIGURE 17 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 120
  • FIGURE 18 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 120
  • FIGURE 19 GLOBAL EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE 121
  • FIGURE 20 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022 129
  • FIGURE 21 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION) 130
  • FIGURE 22 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030) 130
  • FIGURE 23 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE 131
  • FIGURE 24 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022 140
  • FIGURE 25 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION) 141
  • FIGURE 26 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030) 141
  • FIGURE 27 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE 142
  • FIGURE 28 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022 146
  • FIGURE 29 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION) 147
  • FIGURE 30 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030) 147
  • FIGURE 31 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE 148
  • FIGURE 32 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022 154
  • FIGURE 33 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 155
  • FIGURE 34 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 155
  • FIGURE 35 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 156
  • FIGURE 36 GLOBAL EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 162
  • FIGURE 37 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY REGION (2022) 163
  • FIGURE 38 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY REGION (2023 & 2030) 163
  • FIGURE 39 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY REGION (2022 & 2030) 164
  • FIGURE 40 GLOBAL EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE (2023-2030) 164
  • FIGURE 41 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 167
  • FIGURE 42 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 168
  • FIGURE 43 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 168
  • FIGURE 44 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 169
  • FIGURE 45 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 169
  • FIGURE 46 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 197
  • FIGURE 47 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 198
  • FIGURE 48 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 198
  • FIGURE 49 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 199
  • FIGURE 50 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 199
  • FIGURE 51 EUROPE EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 287
  • FIGURE 52 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 288
  • FIGURE 53 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 288
  • FIGURE 54 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 289
  • FIGURE 55 EUROPE EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 289
  • FIGURE 56 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 392
  • FIGURE 57 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 393
  • FIGURE 58 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 393
  • FIGURE 59 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 394
  • FIGURE 60 MIDDLE EAST AND AFRICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 394
  • FIGURE 61 SOUTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 459
  • FIGURE 62 SOUTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 460
  • FIGURE 63 SOUTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 460
  • FIGURE 64 SOUTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 461
  • FIGURE 65 SOUTH AMERICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 461
  • FIGURE 66 GLOBAL EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%) 482
  • FIGURE 67 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%) 483
  • FIGURE 68 EUROPE EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%) 484
  • FIGURE 69 ASIA-PACIFIC EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%) 485
目次

Global epilepsy monitoring devices market is projected to register a substantial CAGR of 5.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

By Product Type (Wearable Devices, Smart Devices, and Conventional Devices), By Type (Generalized Seizures, and Focal Seizure), By Patient Type (Pediatric, Adult, and Geriatric), By End User (Hospitals, Ambulatory Surgical Centres and Clinics, Neurological Centres, Diagnostic Centres, Homecare, and Others), By Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), By Region (North America, Europe, Asia-Pacific, South America, Middle East, and Africa), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Global Epilepsy Monitoring Devices market are:

Rising prevalence of epilepsy

Growing preference for wearable epilepsy monitoring devices

Rising government investments in the epilepsy project

Increased r & d activities in epilepsy

Market Players

Some of the key market players in the Global Epilepsy Monitoring Devices market are listed below:

Apple Inc.

NIHON KOHDEN CORPORATION.

Natus Medical Incorporated.

Owlet

Masimo

Neurotech, LLC

Others

TABLE OF CONTENTS

1 INTRODUCTION 72

  • 1.1 OBJECTIVES OF THE STUDY 72
  • 1.2 MARKET DEFINITION 72
  • 1.3 OVERVIEW OF THE GLOBAL EPILEPSY MONITORING DEVICES MARKET 72
  • 1.4 CURRENCY AND PRICING 74
  • 1.5 LIMITATIONS 74
  • 1.6 MARKETS COVERED 75

2 GLOBAL EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 78

  • 2.1 MARKETS COVERED 78
  • 2.2 GEOGRAPHICAL SCOPE 79
  • 2.3 YEARS CONSIDERED FOR THE STUDY 80
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 81
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 84
  • 2.6 MULTIVARIATE MODELLING 85
  • 2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 86
  • 2.8 DBMR MARKET POSITION GRID 87
  • 2.9 VENDOR SHARE ANALYSIS 89
  • 2.10 MARKET END USER COVERAGE GRID 90
  • 2.11 SECONDARY SOURCES 91

3 EXECUTIVE SUMMARY 92

4 PREMIUM INSIGHTS 95

  • 4.1 PREMIUM INSIGHTS 97
    • 4.1.1 KEY STRATEGIC INITIATIVES 97
    • 4.1.2 SEIZURES OCCURRENCE, BY TIME 98
      • 4.1.2.1 DURING DAY 98
      • 4.1.2.2 DURING SLEEP 99
        • 4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP 99
        • 4.1.2.2.2 NON-REM SLEEP 99
      • 4.1.2.3 DURING NIGHT 99

5 EPIDEMIOLOGY 100

  • 5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY 100
    • 5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE 101
      • 5.1.1.1 TONIC-CLONIC SEIZURES 101
      • 5.1.1.2 ABSENCE SEIZURES 101
    • 5.1.2 FOCAL SEIZURES, BY PATIENT TYPE 102
      • 5.1.2.1 SIMPLE FOCAL SEIZURES 102
      • 5.1.2.2 COMPLEX FOCAL SEIZURES 102
      • 5.1.2.3 SECONDARY GENERALIZED SEIZURES 102

6 GLOBAL EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK 103

  • 6.1 MEDICAL DEVICES 103
  • 6.2 WEARABLE MEDICAL DEVICES 106

7 MARKET OVERVIEW 111

  • 7.1 DRIVERS 113
    • 7.1.1 RISING PREVALENCE OF EPILEPSY 113
    • 7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES 113
    • 7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT 114
    • 7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY 114
  • 7.2 RESTRAINTS 115
    • 7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES 115
    • 7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES 115
  • 7.3 OPPORTUNITIES 116
    • 7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE 116
    • 7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE 116
  • 7.4 CHALLENGES 117
    • 7.4.1 POOR REIMBURSEMENT SCENARIO 117
    • 7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL 117

8 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE 118

  • 8.1 OVERVIEW 119
  • 8.2 WEARABLE DEVICES 122
    • 8.2.1 SMART WATCHES 123
    • 8.2.2 OTHER NON-INVASIVE MONITORING DEVICES 123
  • 8.3 SMART DEVICES 123
    • 8.3.1 MOTION MONITORS 124
    • 8.3.2 1.3.2 VIDEO MONITORS 124
    • 8.3.3 MATTRESS DEVICES 124
    • 8.3.4 OTHERS 125
  • 8.4 CONVENTIONAL DEVICES 125
    • 8.4.1 EEG DEVICE 126
      • 8.4.1.1 AMBULATORY EEG 126
      • 8.4.1.2 CONTINUOUS EEG 126
      • 8.4.1.3 OTHER EEG DEVICES 127
    • 8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE 127
    • 8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE 127
    • 8.4.4 PULSE- OXIMETERS 127
    • 8.4.5 IMPLANTED ADVISORY SYSTEM 127
    • 8.4.6 TRIAXIAL ACCELEROMETER (ACM) 127
    • 8.4.7 MAGNETOMETERS 127
    • 8.4.8 OTHER DEVICES 127

9 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY TYPE 128

  • 9.1 OVERVIEW 129
  • 9.2 FOCAL SEIZURES 132
    • 9.2.1 SIMPLE FOCAL SEIZURES 133
      • 9.2.1.1 SMART DEVICES 133
      • 9.2.1.2 WEARABLE DEVICES 133
      • 9.2.1.3 CONVENTIONAL DEVICES 133
    • 9.2.2 COMPLEX FOCAL SEIZURES 134
      • 9.2.2.1 SMART DEVICES 134
      • 9.2.2.2 WEARABLE DEVICES 134
      • 9.2.2.3 CONVENTIONAL DEVICES 134
    • 9.2.3 SECONDARY GENERALIZED SEIZURES 134
      • 9.2.3.1 SMART DEVICES 135
      • 9.2.3.2 WEARABLE DEVICES 135
      • 9.2.3.3 CONVENTIONAL DEVICES 135
  • 9.3 GENERALIZED SEIZURES 135
    • 9.3.1 TONIC-CLONIC SEIZURES 136
      • 9.3.1.1 SMART DEVICES 137
      • 9.3.1.2 WEARABLE DEVICES 137
      • 9.3.1.3 CONVENTIONAL DEVICES 137
    • 9.3.2 ABSENCE SEIZURES 137
      • 9.3.2.1 SMART DEVICES 137
      • 9.3.2.2 WEARABLE DEVICES 137
      • 9.3.2.3 CONVENTIONAL DEVICES 138

10 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE 139

  • 10.1 OVERVIEW 140
  • 10.2 PEDIATRIC 143
  • 10.3 GERIATRIC 143
  • 10.4 ADULTS 144

11 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY END USER 145

  • 11.1 OVERVIEW 146
  • 11.2 HOSPITALS 149
  • 11.3 HOMECARE SETTINGS 149
  • 11.4 NEUROLOGY CENTRES 150
  • 11.5 DIAGNOSTIC CENTRES 150
  • 11.6 AMBULATORY SURGICAL CENTRES AND CLINICS 151
  • 11.7 OTHERS 152

12 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL 153

  • 12.1 OVERVIEW 154
  • 12.2 RETAIL SALES 157
  • 12.3 ONLINE SALES 157
  • 12.4 DIRECT TENDERS 158
  • 12.5 OTHERS 158

13 GLOBAL EPILEPSY MONITORING DEVICES MARKET, BY REGION 160

  • 13.1 OVERVIEW 161
  • 13.2 NORTH AMERICA 166
    • 13.2.1 U.S. 177
    • 13.2.2 CANADA 184
    • 13.2.3 MEXICO 190
  • 13.3 ASIA-PACIFIC 196
    • 13.3.1 CHINA 207
    • 13.3.2 INDIA 213
    • 13.3.3 JAPAN 219
    • 13.3.4 SOUTH KOREA 225
    • 13.3.5 SINGAPORE 231
    • 13.3.6 THAILAND 237
    • 13.3.7 MALAYSIA 243
    • 13.3.8 INDONESIA 249
    • 13.3.9 AUSTRALIA 255
    • 13.3.10 PHILIPPINES 261
    • 13.3.11 VIETNAM 267
    • 13.3.12 NEW ZEALAND 273
    • 13.3.13 TAIWAN 279
    • 13.3.14 REST OF ASIA-PACIFIC 285
  • 13.4 EUROPE 286
    • 13.4.1 GERMANY 297
    • 13.4.2 U.K. 303
    • 13.4.3 FRANCE 309
    • 13.4.4 ITALY 315
    • 13.4.5 SPAIN 321
    • 13.4.6 RUSSIA 327
    • 13.4.7 NETHERLANDS 333
    • 13.4.8 SWITZERLAND 340
    • 13.4.9 BELGIUM 346
    • 13.4.10 TURKEY 352
    • 13.4.11 DENMARK 358
    • 13.4.12 SWEDEN 365
    • 13.4.13 NORWAY 371
    • 13.4.14 POLAND 377
    • 13.4.15 FINLAND 383
    • 13.4.16 REST OF EUROPE 390
  • 13.5 MIDDLE EAST AND AFRICA 391
    • 13.5.1 SOUTH AFRICA 402
    • 13.5.2 UAE 409
    • 13.5.3 EGYPT 415
    • 13.5.4 SAUDI ARABIA 421
    • 13.5.5 KUWAIT 427
    • 13.5.6 ISRAEL 433
    • 13.5.7 BAHRAIN 439
    • 13.5.8 OMAN 445
    • 13.5.9 QATAR 451
    • 13.5.10 REST OF MIDDLE EAST AND AFRICA 457
  • 13.6 SOUTH AMERICA 458
    • 13.6.1 BRAZIL 468
    • 13.6.2 ARGENTINA 474
    • 13.6.3 REST OF SOUTH AMERICA 481

14 GLOBAL EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE 482

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 482
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 483
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 484
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 485

15 SWOT 486

16 COMPANY PROFILES 487

  • 16.1 NIHON KOHDEN CORPORATION. 487
    • 16.1.1 COMPANY SNAPSHOT 487
    • 16.1.2 RECENT FINANCIALS 487
    • 16.1.3 COMPANY SHARE ANALYSIS 488
    • 16.1.4 PRODUCT PORTFOLIO 488
    • 16.1.5 RECENT DEVELOPMENT 488
  • 16.2 MASIMO 489
    • 16.2.1 COMPANY SNAPSHOT 489
    • 16.2.2 RECENT FINANCIALS 489
    • 16.2.3 COMPANY SHARE ANALYSIS 490
    • 16.2.4 PRODUCT PORTFOLIO 490
    • 16.2.5 RECENT DEVELOPMENT 490
  • 16.3 APPLE INC. 492
    • 16.3.1 COMPANY SNAPSHOT 492
    • 16.3.2 REVENUE ANALYSIS 492
    • 16.3.3 COMPANY SHARE ANALYSIS 493
    • 16.3.4 PRODUCT PORTFOLIO 493
    • 16.3.5 RECENT DEVELOPMENTS 493
  • 16.4 NATUS MEDICAL INCORPORATED. 494
    • 16.4.1 COMPANY SNAPSHOT 494
    • 16.4.2 RECENT FINANCIALS 494
    • 16.4.3 COMPANY SHARE ANALYSIS 496
    • 16.4.4 PRODUCT PORTFOLIO 496
    • 16.4.5 RECENT DEVELOPMENT 497
  • 16.5 OWLET. 498
    • 16.5.1 COMPANY SNAPSHOT 498
    • 16.5.2 REVENUE ANALYSIS 498
    • 16.5.3 COMPANY SHARE ANALYSIS 499
    • 16.5.4 PRODUCT PORTFOLIO 499
    • 16.5.5 RECENT DEVELOPMENT 499
  • 16.6 ACTIGRAPH, LLC. 501
    • 16.6.1 COMPANY SNAPSHOT 501
    • 16.6.2 PRODUCT PORTFOLIO 501
    • 16.6.3 RECENT DEVELOPMENT 501
  • 16.7 ADVANCED BRAIN MONITORING, INC. 503
    • 16.7.1 COMPANY SNAPSHOT 503
    • 16.7.2 PRODUCT PORTFOLIO 503
    • 16.7.3 RECENT DEVELOPMENT 505
  • 16.8 CAPTUREPROFF INC. 505
    • 16.8.1 COMPANY SNAPSHOT 505
    • 16.8.2 PRODUCT PORTFOLIO 505
    • 16.8.3 RECENT DEVELOPMENT 506
  • 16.9 EMPATICA INC. 506
    • 16.9.1 COMPANY SNAPSHOT 506
    • 16.9.2 PRODUCT PORTFOLIO 506
    • 16.9.3 RECENT DEVELOPMENT 506
  • 16.10 EPIHUNTER 507
    • 16.10.1 COMPANY SNAPSHOT 507
    • 16.10.2 PRODUCT PORTFOLIO 507
    • 16.10.3 RECENT DEVELOPMENT 508
  • 16.11 EPILERT 508
    • 16.11.1 COMPANY SNAPSHOT 508
    • 16.11.2 PRODUCT PORTFOLIO 508
    • 16.11.3 RECENT DEVELOPMENT 509
  • 16.12 EPILEPSY ALARMS UK 510
    • 16.12.1 COMPANY SNAPSHOT 510
    • 16.12.2 PRODUCT PORTFOLIO 510
    • 16.12.3 RECENT DEVELOPMENT 511
  • 16.13 EPI USA. 511
    • 16.13.1 COMPANY SNAPSHOT 511
    • 16.13.2 PRODUCT PORTFOLIO 511
    • 16.13.3 RECENT DEVELOPMENT 511
  • 16.14 EPIVIEW 512
    • 16.14.1 COMPANY SNAPSHOT 512
    • 16.14.2 PRODUCT PORTFOLIO 512
    • 16.14.3 RECENT DEVELOPMENT 512
  • 16.15 FREQUENCY PRECISION. 513
    • 16.15.1 COMPANY SNAPSHOT 513
    • 16.15.2 PRODUCT PORTFOLIO 513
    • 16.15.3 RECENT DEVELOPMENT 513